Cooper Companies completes acquisition of Sauflon

Article

The Cooper Companies, Inc. recently completed its acquisition of Sauflon Pharmaceuticals Limited in a transaction valued at approximately $1.2 billion, expanding CooperVision’s range of contact lens offerings.

Pleasanton, CA-The Cooper Companies, Inc. recently completed its acquisition of Sauflon Pharmaceuticals Limited in a transaction valued at approximately $1.2 billion, expanding CooperVision’s range of contact lens offerings.

Sauflon joins U.S. contact lens market

“We’re approaching the daily disposables category with a new, multi-tier model. By adding the Sauflon portfolio to our already-strong MyDay and Proclear brand choices, we’re bringing forward multiple contact lens families designed and marketed for distinct wearer segments,” says Daniel G. McBride, president of CooperVision, Inc. “This approach to the market provides practitioners the ability to offer a daily disposable lens for every eye and every budget, which should further accelerate both practice growth and category momentum.”

According to the company, CooperVision is now working to combine both companies’ employees, processes, and pipelines. Customers should continue working with their current CooperVision and Sauflon representatives, support resources, and ordering mechanisms until advised otherwise.

Recent Videos
Jeffrey Walline, OD, PhD, FAAO, overviews a presentation he gave on the Bifocal Lenses in Nearsighted Kids 2 (BLINK2) cohort study at the Collaborative Community on Ophthalmic Innovation (CCOI).
Dr Jamie Kuzniar discusses higher order aberrations and premium scleral lenses
From contact lens dropout to addressing diabetic retinopathy in rural communities, optometrists choose an area of eye care research that they would expand, given the appropriate resources.
In 2 weeks, the study participant's dry eye symptoms improved from 76 to 43 on a 0-100 rating scale, according to Marc-Matthias Schulze, PhD, Dipl Ing.
Kerry Giedd, OD, MS, FAAO, was 1 of 20 investigators around the country for a study evaluating the daily disposable contact lens.
David Geffen, OD, FAAO, gave a poster presentation titled "Revolutionizing Comfort: Unveiling the Potential of Perfluorohexyloctane Eyedrops for Contact Lens Wearers" at this year's Academy meeting.
In a study, a xenon slide illuminator was employed to mimic natural outdoor colors, allowing researchers to test brightness perception using a brightness-matching method, explains Billy R. Hammond.
Christi Closson, OD, FAAO, provides insight on what other ODs learned about Johnson & Johnson's contact lens technology.
Dana Shannon, OD, FAAO, details The Contact Lens Instiute's latest report, The Dropout Dilemma.
Billy R. Hammond details the study, which explored how HEV-light filtering, specifically in the 380-440 nanometer range, impacts visual comfort for patients with presbyopia.
© 2025 MJH Life Sciences

All rights reserved.